Thevis Mario, Schänzer Wilhelm
Institute of Biochemistry and Center for Preventive Doping Research, German Sport University Cologne, Carl-Diem Weg 6, 50933 Cologne, Germany.
Mass Spectrom Rev. 2007 Jan-Feb;26(1):79-107. doi: 10.1002/mas.20107.
Owing to the sensitive, selective, and unambiguous nature of mass spectrometric analyses, chromatographic techniques interfaced to various kinds of mass spectrometers have become the most frequently employed strategy in the fight against doping. To obtain utmost confidence in analytical assays, mass spectrometric characterization of target analytes and typical dissociation pathways have been utilized as basis for the development of reliable and robust screening as well as confirmation procedures. Methods for qualitative and/or quantitative determinations of prohibited low and high molecular weight drugs have been established in doping control laboratories preferably employing gas or liquid chromatography combined with electron, chemical, or atmospheric pressure ionization followed by analyses using quadrupole, ion trap, linear ion trap, or hyphenated techniques. The versatility of modern mass spectrometers enable specific as well as comprehensive measurements allowing sports drug testing laboratories to determine the misuse of therapeutics such as anabolic-androgenic steroids, stimulants, masking agents or so-called designer drugs in athletes' blood or urine specimens, and a selection of recent developments is summarized in this review.
由于质谱分析具有灵敏、选择性强和明确的特点,与各类质谱仪联用的色谱技术已成为反兴奋剂斗争中最常用的策略。为了在分析检测中获得最大程度的可信度,目标分析物的质谱表征和典型的解离途径已被用作开发可靠且稳健的筛查以及确证程序的基础。在兴奋剂检测实验室中,已建立了用于定性和/或定量测定禁用的低分子量和高分子量药物的方法,这些方法最好采用气相或液相色谱与电子、化学或大气压电离联用,然后使用四极杆、离子阱、线性离子阱或联用技术进行分析。现代质谱仪的多功能性使得能够进行特定以及全面的测量,从而使运动药物检测实验室能够确定运动员血液或尿液样本中是否滥用了诸如合成代谢雄激素类固醇、兴奋剂、掩蔽剂或所谓的设计药物等治疗药物,本文综述了一些最新进展。